Consensus Among International Facial Therapy Experts for the Management of Adults with Unilateral Facial Palsy: A Two-Stage Nominal Group and Delphi Study
Facial Plastic Surgery & Aesthetic Medicine · 01.07.2024 · 26 (4) · 405-417
DOI: 10.1089/fpsam.2023.0101 ↗Kurz gefasst
Delphi-Studie in der Zeitschrift Facial Plastic Surgery & Aesthetic Medicine, online erschienen am 26.07.2024. Verfasst von Catriona Neville und 4 weiteren Autor:innen. Beteiligte Einrichtung: Facial Palsy MDT, Queen Victoria Hospital, East Grinstead, United Kingdom. Hauptthemen laut MEDLINE: Facial Paralysis, Delphi Technique. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Nonsurgical rehabilitation of unilateral peripheral facial palsy (FP) varies globally with controversy regarding best practice.
Objective
To develop facial therapist consensus regarding what should be included or excluded in rehabilitation of adults with FP of any etiology. Three clinical presentations: flaccid, paretic and synkinetic, were separately considered. Methodology: A two-stage study was conducted: a nominal group technique (NGT) to develop a questionnaire plus Delphi study. Delphi participants were recruited worldwide, through an experience-based inclusion questionnaire. The final Delphi questionnaire included 166 items for each clinical presentation covering assessment, outcome measures, and interventions, for example, education, eye care, neuromuscular retraining, and electrical modalities. Inclusion/exclusion agreement was set at 80%, indicating participant consensus. Items reaching 70–79% were deemed “near-included/near-excluded.” Results: Averaged across all presentations, 24.9% of the 166 items were included, (e.g., Sunnybrook Facial Grading System, patient education and neuromuscular retraining), 26.9% of the 166 items were excluded, (e.g., gross strengthening and electrical stimulation); 48.2% were neither included nor excluded.
Conclusion
This study brings together the global community's expertise as a first step toward establishing best practice for specialist facial therapy. It is hoped this will guide clinical decision making, advance research, and optimize patient outcomes in this challenging field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Facial Palsy MDT, Queen Victoria Hospital, East Grinstead, United Kingdom.
- The Facial Rehabilitation Centre Ltd, United Kingdom.
- Department of Physiotherapy, Formerly of Radboud University Medical Centre, Nijmegen, The Netherlands.
- Facial Retraining LLC, Madison, Wisconsin, USA.
- Franciscan Missionaries of Our Lady Health System, Our Lady of the Lake Regional Medical Centre, Centre for Facial Plastic Surgery, Baton Rouge, Louisiana, USA.
- Rankin Physiotherapy, Burnaby, British Columbia, Canada.
ORCID-Profile: Catriona Neville, Carien Beurskens, Jackie Diels, Sara MacDowell, Susan Rankin
Zitieren
APA
Neville, C., Beurskens, C., Diels, J., MacDowell, S., & Rankin, S. (2024). Consensus Among International Facial Therapy Experts for the Management of Adults with Unilateral Facial Palsy: A Two-Stage Nominal Group and Delphi Study. Facial Plastic Surgery & Aesthetic Medicine, 26(4), 405-417. https://doi.org/10.1089/fpsam.2023.0101
Vancouver
Neville C, Beurskens C, Diels J, MacDowell S, Rankin S. Consensus Among International Facial Therapy Experts for the Management of Adults with Unilateral Facial Palsy: A Two-Stage Nominal Group and Delphi Study. Facial Plastic Surgery & Aesthetic Medicine. 2024;26(4):405-417. doi:10.1089/fpsam.2023.0101
BibTeX
@article{Neville2024,
author = {Neville, Catriona and Beurskens, Carien and Diels, Jackie and MacDowell, Sara and Rankin, Susan},
title = {Consensus Among International Facial Therapy Experts for the Management of Adults with Unilateral Facial Palsy: A Two-Stage Nominal Group and Delphi Study},
journal = {Facial Plastic Surgery & Aesthetic Medicine},
year = {2024},
volume = {26},
number = {4},
pages = {405--417},
doi = {10.1089/fpsam.2023.0101}
}
EUVIMED